Stabilization and depot neuroleptic dosages.

Little is known about the stabilization phase of schizophrenia. To address this deficiency, we studied the prescribing patterns of fluphenazine decanoate (FZD) for a cohort of schizophrenic patients recovering from an acute psychotic episode who were being followed in the Treatment Strategies in Schizophrenia (TSS) multi-site maintenance study. Dosage data from the first 208 successfully-stabilized TSS subjects were examined. We hypothesized five groups on the basis of dosage prescribed and dosage stability over time: (1) STABLE HIGH, (2) STABLE INTERMEDIATE, (3) STABLE LOW, (4) UNSTABLE RAISING, and (5) UNSTABLE LOWERING. The dosage patterns were rated and analyzed against predictive and outcome variables. Most of the subjects (n = 168, or 82%) fit one of the five hypothesized dosage pattern groups. Our preliminary findings are as follows: (1) all groups improved during stabilization; (2) baseline symptom severity did not distinguish among dosage pattern groups; (3) STABLE dose groups needed less time to stabilize than did the UNSTABLE groups, but the STABLE groups did not have a better medication response; (4) many of the UNSTABLE LOWERING subjects apparently received a "loading dose" strategy (e.g., initial FZD dose > or = 25 mg), which was paradoxically associated with a longer stabilization time.
AuthorsP Weiden, N R Schooler, J B Severe, J H Lee, S C Schulz
JournalPsychopharmacology bulletin (Psychopharmacol Bull) Vol. 29 Issue 2 Pg. 269-75 ( 1993) ISSN: 0048-5764 [Print] United States
PMID8290676 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Delayed-Action Preparations
  • fluphenazine depot
  • Fluphenazine
  • Adult
  • Delayed-Action Preparations
  • Fluphenazine (administration & dosage, analogs & derivatives, therapeutic use)
  • Humans
  • Male
  • Schizophrenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: